Skip to main content

Advertisement

Log in

The Epidemiology, Clinical Course, and Management of Snakebites in the North American Snakebite Registry

  • Original Article
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

Abstract

The American College of Medical Toxicology established the North American Snakebite Registry (NASBR), a national database of detailed, prospectively collected information regarding snake envenomation in the United States, in 2013. This report describes the epidemiology, clinical course, and management of snakebites in the NASBR. All cases entered into the NASBR between January 1, 2013 and December 31, 2015 were identified. Descriptive statistics are used to report results. Fourteen sites in 10 states entered 450 snakebites. Native species comprised 99% of cases, almost all of which were pit viper bites. 56.3% were identified as rattlesnakes and 29.4% as copperheads. 69.3% were male and 28.2% were children age 12 and under. Fifty-four percent of bites were on the lower extremity. Twenty-seven percent of patients with lower extremity bites were not wearing shoes. Common tissue findings associated with envenomation were swelling, ecchymosis, and erythema. Systemic effects and hematologic toxicity were more common in rattlesnake than copperhead or cottonmouth envenomations. Crotalidae Polyvalent Immune Fab antivenom was given to 84% of patients. Twelve patients (4.3%) were re-admitted to the hospital after completion of treatment. Eight were re-treated with antivenom. The NASBR gathers detailed data on venomous snakebites across the US. In its initial years, useful information has already been gained. Data regarding footwear will inform public health interventions and education, and information regarding the clinical presentation may help physicians better anticipate effects and manage snakebite. As the number of cases in the NASBR grows, associations between patient-related factors and outcomes may be studied.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Seifert SA, Boyer LV, Benson BE, Rogers JJ. AAPCC database characterization of native U.S. venomous snake exposures, 2001-2005. Clin Toxicol (Phila). 2009;47(4):327–35. https://doi.org/10.1080/15563650902870277.

    Article  Google Scholar 

  2. Bush SP, Ruha AM, Seifert SA, et al. Comparison of F(ab’)2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial. Clin Toxicol (Phila). 2015;53(1):37–45. https://doi.org/10.3109/15563650.2014.974263.

    Article  CAS  Google Scholar 

  3. Farrugia LA, Rhyee SH, Campleman SL, et al. The Toxicology Investigators Consortium Case Registry—the 2015 experience. J Med Toxicol. 2016; https://doi.org/10.1007/s13181-016-0580-6.

  4. Spyres MB, Ruha AM, Seifert S, Onisko N, Padilla-Jones A, Smith EA. Occupational snake bites: a prospective case series of patients reported to the ToxIC North American Snakebite Registry. J Med Toxicol. 2016; https://doi.org/10.1007/s13181-016-0555-7.

  5. Lavonas EJ, Ruha AM, Banner W, et al. Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med. 2011;11:2. https://doi.org/10.1186/1471-227x-11-2.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kleinshmidt KRA, Wax P, et al. Acute adverse effects associated with the administration of FabAV within the North American Snakebite Registry. J Med Toxicol. 2017;13(1)

  7. Correa JA, Fallon SC, Cruz AT, et al. Management of pediatric snake bites: are we doing too much? J Pediatr Surg. 2014;49(6):1009–15. https://doi.org/10.1016/j.jpedsurg.2014.01.043.

    Article  PubMed  Google Scholar 

  8. Cannon R, Ruha AM, Kashani J. Acute hypersensitivity reactions associated with administration of crotalidae polyvalent immune Fab antivenom. Ann Emerg Med. 2008;51(4):407–11. https://doi.org/10.1016/j.annemergmed.2007.09.036.

    Article  PubMed  Google Scholar 

  9. Roth B, Sharma K, Onisko N, Chen T. Prospective evaluation of pain, swelling, and disability from copperhead envenomation. Clin Toxicol (Phila). 2016;54(3):271–6. https://doi.org/10.3109/15563650.2015.1130227.

    Article  CAS  Google Scholar 

  10. Levine M, Ruha AM, Padilla-Jones A, Gerkin R, Thomas SH. Bleeding following rattlesnake envenomation in patients with preenvenomation use of antiplatelet or anticoagulant medications. Acad Emerg Med. 2014;21(3):301–7. https://doi.org/10.1111/acem.12333.

    Article  PubMed  Google Scholar 

  11. Dart RC, Seifert SA, Boyer LV, et al. A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med. 2001;161(16):2030–6.

    Article  CAS  PubMed  Google Scholar 

  12. LaMonica GE, Seifert SA, Rayburn WF. Rattlesnake bites in pregnant women. J Reprod Med. 2010;55(11–12):520–2.

    PubMed  Google Scholar 

  13. Darracq MA, Cantrell FL, Klauk B, Thornton SL. A chance to cut is not always a chance to cure- fasciotomy in the treatment of rattlesnake envenomation: a retrospective poison center study. Toxicon. 2015;101:23–6. https://doi.org/10.1016/j.toxicon.2015.04.014.

    Article  CAS  PubMed  Google Scholar 

  14. O'Neil ME, Mack KA, Gilchrist J, Wozniak EJ. Snakebite injuries treated in United States emergency departments, 2001-2004. Wilderness Environ Med. 2007;18(4):281–7. https://doi.org/10.1580/06-weme-or-080r1.1.

    Article  PubMed  Google Scholar 

  15. Mowry JB, Spyker DA, Brooks DE, Zimmerman A, Schauben JL. 2015 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 33rd annual report. Clin Toxicol (Phila). 2016;54(10):924–1109. https://doi.org/10.1080/15563650.2016.1245421.

    Article  CAS  Google Scholar 

  16. Curry SC, Horning D, Brady P, Requa R, Kunkel DB, Vance MV. The legitimacy of rattlesnake bites in central Arizona. Ann Emerg Med. 1989;18(6):658–63.

    Article  CAS  PubMed  Google Scholar 

  17. Tanen D, Ruha A, Graeme K, Curry S. Epidemiology and hospital course of rattlesnake envenomations cared for at a tertiary referral center in Central Arizona. Acad Emerg Med. 2001;8(2):177–82.

    Article  CAS  PubMed  Google Scholar 

  18. Abbey JM, Jaffar NA, Abugrara HL, Nazim M, Smalligan RD, Khasawneh FA. Epidemiological characteristics, hospital course and outcome of snakebite victims in West Texas. Hosp Pract (1995). 2015;43(4):217–20. https://doi.org/10.1080/21548331.2015.1071637.

    Article  Google Scholar 

  19. Spano S, Macias F, Snowden B, Vohra R. Snakebite Survivors Club: retrospective review of rattlesnake bites in Central California. Toxicon. 2013;69:38–41. https://doi.org/10.1016/j.toxicon.2012.11.015.

    Article  CAS  PubMed  Google Scholar 

  20. Wasko DK, Bullard SG. An analysis of media-reported venomous snakebites in the United States, 2011-2013. Wilderness Environ Med. 2016;27(2):219–26. https://doi.org/10.1016/j.wem.2016.01.004.

    Article  PubMed  Google Scholar 

  21. LoVecchio F, Klemens J, Welch S, Rodriguez R. Antibiotics after rattlesnake envenomation. J Emerg Med. 2002;23(4):327–8.

    Article  PubMed  Google Scholar 

  22. Corbett B, Clark RF. North American snake envenomation. Emerg Med Clin North Am. 2017;35(2):339–54. https://doi.org/10.1016/j.emc.2016.12.003.

    Article  PubMed  Google Scholar 

  23. Cumpston KL. Is there a role for fasciotomy in Crotalinae envenomations in North America? Clin Toxicol (Phila). 2011;49(5):351–65. https://doi.org/10.3109/15563650.2011.597032.

    Article  CAS  Google Scholar 

  24. Toxicology ACMT and AACT. Choosing wisely recommendations. In: Choosing Wisely. American Board of Internal Medicine Foundation. 2017. http://www.choosingwisely.org/clinician-lists/-parentSociety=American_College_of_Medical_Toxicology_and_The_American_Academy_of_Clinical_Toxicology. Accessed 25 May 2017.

  25. BTG CroFab.com. In: Accessed 16 July 2015.

  26. Spyres MB, Skolnik AB, Padilla-Jones A, et al. Rattlesnake envenomations treated with and without maintenance antivenom. Clin Toxicol. 2016;54(8):660.

  27. Lavonas EJ, Khatri V, Daugherty C, Bucher-Bartelson B, King T, Dart RC. Medically significant late bleeding after treated crotaline envenomation: a systematic review. Ann Emerg Med. 2014;63(1):71–78 e1. https://doi.org/10.1016/j.annemergmed.2013.03.002.

    Article  PubMed  Google Scholar 

Download references

Funding

The 2013–2015 ACMT North American Snakebite Registry was supported by unrestricted grants to ACMT from BTG International.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Anne-Michelle Ruha.

Ethics declarations

Conflicts of Interest

The authors have no conflicts of interest to declare. Grant support allowed ACMT to compensate individuals or sites entering cases into the registry, but study authors did not benefit financially from participating in this research.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruha, AM., Kleinschmidt, K.C., Greene, S. et al. The Epidemiology, Clinical Course, and Management of Snakebites in the North American Snakebite Registry. J. Med. Toxicol. 13, 309–320 (2017). https://doi.org/10.1007/s13181-017-0633-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-017-0633-5

Keywords

Navigation